Clostridioides difficile Infection Severity (IDSA)
ورودیهای بالینی بیمار
حداقل ۱۰۰۰ — حداکثر ۲۰۰۰۰۰ • واحد: /uL
حداقل ۰.۲ — حداکثر ۲۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- classified≥ 0
The Clostridioides difficile Infection Severity (IDSA) calculates predicting invasive bacterial infection probability and quantifying systemic host response to sepsis. Key inputs include wbc per ul. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
IDSA/SHEA severity classification for C. difficile infection.
Clinical Indication
The Clostridioides difficile Infection Severity (IDSA) is indicated for bedside clinical practice to support IDSA/SHEA severity classification for C. difficile infection.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
Fulminant: hypotension/shock, ileus, or megacolon. Severe: WBC>=15000 or SCr>1.5. Else non-severe.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| wbc_per_ul | integer | Yes | WBC count(/uL) |
| creatinine_mg_dl | float | Yes | Serum creatinine(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | classified | CDI severity |
Evidence-Based References (EBM)
- Johnson S, et al. Clinical Practice Guidelines for Clostridioides difficile Infection, 2021 Focused Update. Clin Infect Dis. 2021;73(5):e1389-e1419.